Physician profile
Britney Gore
NPI 1447885710
$2,400.15
in general payments reported to CMS, 2019-2025
23 companies · $664 in 2025
The $664 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $313 · 2022: $229 · 2023: $625 · 2024: $570 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.57 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $576.83 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $307.49 | 2021-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $275.70 | 2021-2025 | Verquvo, Belsomra, Steglujan |
| Glaxosmithkline, LLC. | $195.51 | 2022-2025 | Nucala, Bexsero |
| Bayer Healthcare Pharmaceuticals INC. | $194.77 | 2022-2025 | |
| Abbvie INC. | $169.58 | 2021-2024 | |
| Lilly USA, LLC | $150.69 | 2021-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $72.10 | 2023-2025 | Trintellix |
| Novo Nordisk INC | $63.24 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $58.99 | 2024 | Nuvent, Propel |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $51.54 | 2024-2025 | Airsupra |
| Amgen INC. | $51.42 | 2021-2024 | Prolia, Evenity, Repatha |
| Kowa Pharmaceuticals America, INC. | $25.52 | 2021 | |
| Amarin Pharma, INC. | $21.40 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $20.62 | 2021 | |
| Inspire Medical Systems, INC. | $19.76 | 2023 | Inspire |
| Jazz Pharmaceuticals INC. | $15.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.75 | 2024 | |
| Eisai INC. | $15.64 | 2021 | |
| Kaleo, INC. | $15.28 | 2022 | |
| Exact Sciences Corporation | $15.25 | 2024 | Cologuard Collection Kit |
| Hikma Pharmaceuticals USA | $14.20 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britney Gore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.